ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,525Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1125

$1.26M Total Retail Price of All Prescriptions

Rank: 55 out of 1125

855 Patients Receiving at Least One Drug in Part D
64% Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 855 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 855 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 1,260 869 208 1 2
OMEPRAZOLE 1,208 855 215 2 4
METOPROLOL TARTRATE 1,064 713 164 3 11
FUROSEMIDE 1,042 889 180 4 7
LEVOTHYROXINE SODIUM 810 617 106 5 3
SIMVASTATIN 708 478 114 6 5
POTASSIUM CHLORIDE 680 570 114 7 14
WARFARIN SODIUM 670 539 67 8 18
AMLODIPINE BESYLATE 589 442 91 9 6
METFORMIN HCL 568 341 96 10 8
GABAPENTIN 520 261 89 11 10
ATORVASTATIN CALCIUM 495 368 78 12 9
METOPROLOL SUCCINATE 477 355 70 13 17
HYDROCHLOROTHIAZIDE 470 344 85 14 12
CLOPIDOGREL 459 315 78 15 15
HYDROCODONE-ACETAMINOPHEN 426 273 145 S3 16 1
RANITIDINE HCL 393 296 65 17 24
NEXIUM 387 192 64 18 20
CARVEDILOL 377 289 59 19 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 375 258 72 20 28
PRAVASTATIN SODIUM 373 246 65 21 13
AMITRIPTYLINE HCL 356 237 63 R 22 51
GLIPIZIDE 334 248 51 23 64
AZITHROMYCIN 294 206 220 24 47
TRAZODONE HCL 255 179 60 25 36
DIGOX 208 171 30 26 97
IBUPROFEN 206 87 60 27 65
CITALOPRAM HBR 196 144 44 28 19
GLYBURIDE MICRONIZED 192 135 38 R 29 233
SERTRALINE HCL 180 129 38 30 22
DONEPEZIL HCL 178 173* 31 31 42
PROAIR HFA 178 117 56 31 39
ADVAIR DISKUS 178 105 40 31 61
ISOSORBIDE MONONITRATE ER 178 145 30 31 43
ATENOLOL 168 113 26 35 21
FLUTICASONE PROPIONATE 165 112 73 36 41
TAMSULOSIN HCL 157 117 32 37 34
LANTUS 157 72 29 37 66
DILTIAZEM 24HR CD 154 109 19 39 136
CEFDINIR 153 100 124 40 148
QUETIAPINE FUMARATE 153 124 28 A 40 76
POLYETHYLENE GLYCOL 3350 153 128 50 40 54
FLUOXETINE HCL 150 111 21 43 48
PANTOPRAZOLE SODIUM 149 115 28 44 27
CRESTOR 149 105 26 44 29
NAPROXEN 148 84 42 46 81
ALPRAZOLAM 147 115 50 B 47 16
FENOFIBRATE* 147 105 27 47 55
PAROXETINE HCL 145 58 27 49 49
NOVOLIN 70-30 139 78 23 50 232
SPIRIVA 133 95 32 51 60
VENTOLIN HFA 129 82 46 52 117
CYMBALTA 125 64 20 53 45
PREDNISONE 124 91 42 54 44
THEOPHYLLINE ANHYDROUS 123 104 19 55 166
ROPINIROLE HCL 122 65 21 56 75
INSULIN SYRINGE* 122 96 25 56 151
DIOVAN 120 105 22 58 57
TRAMADOL HCL 118 76 46 59 31
TRIAMTERENE-HCTZ 118 78 18 59 69
NAMENDA 116 116 16 61 38
GLYBURIDE 115 93 18 R 62 90
TEMAZEPAM 114 101 45 B 63 100
MIRTAZAPINE 109 87 23 64 62
LOSARTAN POTASSIUM 108 87 21 65 23
MONTELUKAST SODIUM 107 62 23 66 35
HYDRALAZINE HCL 106 81 16 67 92
HYDROXYZINE PAMOATE 106 73 31 R 67 163
ALENDRONATE SODIUM 106 77 20 67 50
SPIRONOLACTONE 104 99* 19 70 78
JANUVIA 100 95* 19 71 53
ALLOPURINOL 99 52 17 72 40
GLIPIZIDE ER 93 82 14 73 135
TRIAMTERENE-HYDROCHLOROTHIAZID 91 <11 <11 74 195
SYMBICORT 87 74 23 75 107
CLONIDINE HCL 85 50 14 76 58
DOXAZOSIN MESYLATE 84 73 14 77 91
BACLOFEN 84 52 26 77 116
MELOXICAM 84 66 32 77 25
CIPROFLOXACIN HCL 83 58 65 80 68
NITROSTAT 80 64 34 81 177
LEVEMIR 79 38 20 82 161
COMBIVENT RESPIMAT 78 53 19 83 226
LOVAZA 78 73* 15 83 99
LANSOPRAZOLE 77 66 19 85 106
KLOR-CON 10 75 46 11 86 125
LOSARTAN-HYDROCHLOROTHIAZIDE 75 44 11 86 56
HUMULIN 70-30 74 <11 <11 88 265
MECLIZINE HCL 73 52 25 89 115
VERAPAMIL ER 73 <11 <11 89 122
DOXYCYCLINE HYCLATE 72 50 53 91 165
EVISTA 70 65* 12 92 134
NIASPAN 69 <11 <11 93 145
DOXEPIN HCL 69 64* 11 93 183
FLUCONAZOLE 68 32 39 95 137
COMBIVENT 68 43 21 95 297
NIFEDIPINE ER 67 55 12 97 142
VOLTAREN 67 51 34 97 194
LORAZEPAM 66 48 22 B 99 30
DILTIAZEM 24HR ER 65 60* 12 100 153
DIVALPROEX SODIUM 65 34 11 100 98
CEPHALEXIN 63 37 52 102 86
METOCLOPRAMIDE HCL 62 39 14 103 126
DILTIAZEM ER 60 32 11 104 162
PRIMIDONE 60 <11 <11 104 234
ESCITALOPRAM OXALATE 60 48 12 104 52
DICLOFENAC SODIUM 58 <11 <11 107 80
CELEBREX 56 31 11 108 83
INSULIN SYRINGE* 56 22 14 108 151
LIDODERM 55 43 29 110 172
CLINDAMYCIN HCL 54 41 43 111 308
VENLAFAXINE HCL ER 54 <11 <11 111 103
AMOX TR-POTASSIUM CLAVULANATE 53 32 47 113 119
KLOR-CON M10 52 40 15 114 154
LEVOFLOXACIN 51 37 41 115 67
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.